Polpharma Biologics – Building on early achievements

Opublikowany: 01.12.2022

In the latest issue of Pharma’s Almanac, Guenter Stempfer (Managing Director Duchnice & Board Member) describes Polpharma’s Biologics expansion plans.
Read more about the company growth strategy and constructing of the second manufacturing facility in Duchnice, near Warsaw.
Learn about the new investment and how Polpharma Biologics will provide customers with large-scale manufacturing of drug substance and drug product.

"Polpharma Biologics provides truly integrated contract development and manufacturing services for both branded and biosimilar projects."

written by: Polpharma Biologics

Współpracujmy, aby dostarczać wysokiej jakości leki biopodobne.

Skontaktuj się, aby uzyskać więcej informacji.